Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TechnologyAdvice

- PMLiVE

J&J’s Imbruvica tops Arzerra in phase III trial

Shows improvement over GSK’s drug in haematological malignancies

- PMLiVE

Celgene wins EU pancreatic cancer approval for Abraxane

Adds to drug's existing breast cancer indication

- PMLiVE

Aeterna Zentaris looks to Boehringer for science head

Richard Sachse joins Canadian firm as chief scientific officer

- PMLiVE

Kala names Howard Rosen as chairman

He is former CEO of Pearl Therapeutics and VP at Gilead

Interview: Beate Wieseler, IQWIG

Head of the department of drug assessment at the German HTA body on taking a pragmatic approach to comparing medicines

- PMLiVE

AstraZeneca expands personalised drug partnership with Horizon

Companies will research drug targets for targeted cancer treatments

- PMLiVE

Key Teva shareholder backs Vigodman as next CEO

Board director tipped to replace Jeremy Levin at Israeli pharma firm

- PMLiVE

Royalty Pharma buys bigger Tecfidera interest

Agrees $510m deal with Biogen Idec for IP share of multiple sclerosis drug

- PMLiVE

GE pays $1bn to bolster life sciences division

Will buy three businesses from Thermo Fisher

- PMLiVE

Disney and Lilly publish diabetes books online

Digital format for resource to help families with children who have type 1 diabetes

- PMLiVE

Covington boosts European life sciences group

New partner and an associate will focus on issues involving EU law

- PMLiVE

AVEO’s financial head joins ImmunoGen

David Johnston appointed chief financial officer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links